mewburn-logo-white mewburn-logo
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • en
  • zh-hans
  • germany
  • ja
  • ko
  • About us
    • About us
    • Working with our Munich Office
    • Our AI Strategy & Action Plan
    • Who we work with
    • How we work with our clients
    • The Mewburn Ellis culture
    • Community giving
    • Inclusion & diversity
      • Inclusion & diversity
      • Gender Pay Gap
      • Women in IP
    • Sustainability
    • Join Mewburn Ellis
      • Join Mewburn Ellis
      • Vacancies
    • Graduate training programme
    • Business partners
      • Business partners
      • Code of conduct
      • Diversity policy
      • Environmental policy
  • Our People
    • Our People
    • View All People
    • Our Leadership Team
  • About you
    • Who we work with
    • I'm an attorney/law firm
    • I'm a university/R&D
    • I'm a corporate
    • I'm an SME
    • I'm a start up/spin out
  • Which service?
    • Services
    • I want to patent an invention
      • I want to patent an invention
      • Chemistry Patents
      • Engineering Patents
      • Life Sciences Patents
      • Patent Disputes
      • Patent Renewals
      • European Patent Validations
      • Pharma Patent Extensions & Regulatory Exclusivity
    • I want to protect a brand
      • I want to protect a brand
      • Register a trade mark
      • Trade mark disputes
      • Trade mark renewals
      • I want to change a domain name
    • I want to protect my design
      • Register a Design
      • Design Renewals
    • I need help with contentious proceedings
      • Contentious proceedings
      • post grant proceedings
      • oppositions or appeals
      • IP litigation or disputes
      • The Unified Patent Court
    • I need some commercial advice
    • I need to validate my European patent
    • I want to renew my ip rights
  • Spotlight on
    • Health
      • Advanced therapeutics
      • Animal health
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future food
      • Medical technologies
      • Microbiome
      • Pharmaceuticals
      • Plants
      • Precision medicine
      • Speciality pharma
    • Technology
      • Artificial Intelligence (AI)
      • Bioinformatics
      • BioProcessing & Industrial BioTech
      • Digital Health
      • Future mobility
      • Green & sustainable technologies
      • Medical technologies
      • New Nuclear Technologies
      • Quantum Technology
      • Software
      • Space Technology
    • Industry
      • 2d materials
      • Automotive
      • Energy storage
      • Green tech
      • Marine & ocean engineering
      • Medical devices
      • Polymers
      • Pharmaceuticals
      • Plants
      • Speciality pharma
      • Synthetic biology
    • Intellectual property
      • Brexit
      • Green ip
      • Ip litigation
      • Oppositions - chemistry & materials
      • Oppositions - engineering & ICT
      • Oppositions - life sciences
      • UPC
      • Women in ip
  • Knowledge hub
    • Law & practice library
    • News, insights & features
    • Special reports
    • Films
    • Events and Webinars
  • Contact us
    • Offices
    • 8 Bishopsgate
    • Residencies
  • All topics
  • Forward
  • Artificial Intelligence
  • Battery Technologies
  • Bioinformatics
  • Brexit
  • Chemistry
  • Commercial Advice
  • Community
  • COVID-19
  • Designs
  • Energy Storage
  • Engineering
  • EU Unitary Patent / Unified Patent Court
  • FemTech
  • Future Food Tech
  • Future Mobility
  • Graphene & 2D Materials
  • Green Tech
  • ICT
  • Life Sciences
  • Litigation
  • Marine & Ocean Engineering
  • Materials
  • MedTech
  • Microbiome
  • Nature based materials
  • Nuclear
  • On-Demand
  • Oppositions
  • Patents
  • Pharmaceuticals
  • Plants
  • Polymers
  • Polymer recycling
  • Precision Medicine
  • Quantum Computing
  • SME
  • Software
  • Space Tech
  • Synthetic Biology
  • Trade Marks
UPC Weekly - Playing the longer game – patentee wins on the merits after a failed PI
Matthew Naylor - June 9, 2025

UPC Weekly - Playing the longer game – patentee wins on the merits after a failed PI

2025 Week 23 Sometimes you need to know when to take a step back from enforcing your patent, and ...

UPC Weekly - Juicer patent: no additives but no invention
Matthew Naylor - May 27, 2025

UPC Weekly - Juicer patent: no additives but no invention

2025 Week 21 In April 2024, Korean kitchen appliance firm Hurom launched patent infringement ...

UPC Weekly - ‘Off label’ and off the hook: UPC finds no infringement of second medical use patent
Eliot Ward - May 19, 2025

UPC Weekly - ‘Off label’ and off the hook: UPC finds no infringement of second medical use patent

2025 Week 20 For many years, the EPO has recognised that the novelty and inventiveness of a ...

UPC Weekly - Infringement of product-by-process at the UPC
Lucy Coe - April 14, 2025

UPC Weekly - Infringement of product-by-process at the UPC

2025 Week 15 Another first from the UPC this week – how to go about deciding on infringement and ...

UPC Weekly - Hey, why don’t we all just use the problem-solution approach?
Matthew Naylor - April 7, 2025

UPC Weekly - Hey, why don’t we all just use the problem-solution approach?

2025 Week 14 It’s been a big week at the UPC. So many decisions issued that normally it would be a ...

Historical infringement at the UPC and selecting remedies à la carte
Matthew Naylor - March 17, 2025

Historical infringement at the UPC and selecting remedies à la carte

2025 Week 11 The UPC has already made it clear that you can sue for damages for patent infringement ...

UPC Weekly - UPC Court of Appeal takes a new approach to assessing added subject matter
Matthew Naylor - February 24, 2025

UPC Weekly - UPC Court of Appeal takes a new approach to assessing added subject matter

2025 Week 8 It has always been clear that the UPC Court of Appeal (UPC CoA) would have a hugely ...

UPC Weekly - The UPC’s long arm jurisdiction balances against a strict approach to validity
Matthew Naylor - February 3, 2025

UPC Weekly - The UPC’s long arm jurisdiction balances against a strict approach to validity

2025 Week 5 Long before the UPC opened its doors for business, there was speculation about whether ...

UPC Weekly - Damages and added matter at the UPC
Matthew Naylor - January 20, 2025

UPC Weekly - Damages and added matter at the UPC

2025 Week 3 The UPC has most definitely kicked into gear. Each week there are increasing numbers of ...

UPC Weekly - Alexion v Samsung & Amgen – Patentee’s attempted U-turn on claim interpretation foiled by UPC Court of Appeal
Eliot Ward - January 13, 2025

UPC Weekly - Alexion v Samsung & Amgen – Patentee’s attempted U-turn on claim interpretation foiled by UPC Court of Appeal

2025 Week 2 Tailoring one’s claim interpretation for the jurisdiction at hand can be a canny way of ...

UPC Weekly - Very appealing – preliminary injunction overturned
Matthew Naylor - December 9, 2024

UPC Weekly - Very appealing – preliminary injunction overturned

2024 Week 49 SharkNinja have managed to persuade the UPC Court of Appeal to overturn a preliminary ...

UPC Weekly - Front-loading and obviousness at the UPC
Matthew Naylor - December 2, 2024

UPC Weekly - Front-loading and obviousness at the UPC

2024 Week 48 In NJOY v VMR, the UPC Central Division Paris revoked VMR’s patent EP 3456214 B2 on 27 ...

UPC Weekly - UPC finds infringement using a doctrine of equivalents
Matthew Naylor - November 25, 2024

UPC Weekly - UPC finds infringement using a doctrine of equivalents

2024 Week 47 Back in June 2024 (UPC Weekly 2024 week 23), we set out a few “known unknowns” – ...

UPC Weekly - NJOY duel with Juul
Matthew Naylor - November 11, 2024

UPC Weekly - NJOY duel with Juul

2024 Week 45 5 November 2024 saw two decisions handed down by the UPC Paris Central Division (CD) ...

UPC Weekly - All of the fizz and none of the squeeze
Matthew Naylor - November 4, 2024

UPC Weekly - All of the fizz and none of the squeeze

2024 Week 44 SodaStream v Aarke is a decision on the merits of an infringement case based on EP ...

UPC Weekly - UPC confirms approach to inventive step for life science inventions
Matthew Naylor - October 28, 2024

UPC Weekly - UPC confirms approach to inventive step for life science inventions

2024 Week 43 10x Genomics and NanoString have been duking it out at the UPC since the court opened ...

UPC Weekly - Light emitting diode patent falls into a black hole of invalidity
Matthew Naylor - October 21, 2024

UPC Weekly - Light emitting diode patent falls into a black hole of invalidity

2024 Week 42 Last week we did a deep dive into some LED technology to explain the decision of the ...

UPC Weekly - A pro-patent decision on infringement and validity
Matthew Naylor - October 14, 2024

UPC Weekly - A pro-patent decision on infringement and validity

2024 Week 41 This week we report on Seoul Viosys v Expert Klein, a full decision on infringement ...

UPC Weekly - The first UPC SEP injunction
Matthew Naylor - September 23, 2024

UPC Weekly - The first UPC SEP injunction

2024 Week 38 On 13 September 2024, the UPC Munich Local Division handed down its decision in the ...

UPC Weekly - Let’s brake for a minute, and talk about Tesla
Lucy Coe - September 2, 2024

UPC Weekly - Let’s brake for a minute, and talk about Tesla

2024 Week 35 Last week saw two decisions handed down from the UPC Local Divisions as part of ...

UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo
Matthew Naylor - August 5, 2024

UPC Weekly - UPC revocation versus EPO opposition – playing out in not-so-slow-mo

2024 Week 31 What happens when you have the same parties fighting over revocation of the same ...

UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step
Thomas Wolter - July 22, 2024

UPC Weekly - UPC Munich Central Division sets out a marker on how the UPC should approach inventive step

2024 Week 29 This week saw the first UPC decision on the merits issued in the long-running patent ...

UPC Weekly - UPC overturns EPO opposition division decision on the same prior art
Matthew Naylor - July 8, 2024

UPC Weekly - UPC overturns EPO opposition division decision on the same prior art

2024 Week 27 In the race to be the first UPC division to produce a written decision on a main ...

UPC Weekly - UPC uses EPO approach to added subject matter
Matthew Naylor - June 24, 2024

UPC Weekly - UPC uses EPO approach to added subject matter

2024 Week 25 There was lots of UPC news to hold the interest this week but for me the standout was ...

More

  • Slavery Act
  • Legal Notices
  • Terms and Conditions
  • Privacy
  • Forward Community Programme
  • Client Login
  • Join Mewburn Ellis

Follow us

Subscribe

Sign up to Forward: news, insights and features from Mewburn Ellis

Contact

  • mail@mewburn.com
  • London:

    +44 (0)20 7776 5300
  • Bristol:

    +44 (0)117 945 1234
  • Cambridge:

    +44 (0)1223 420383
  • Manchester:

    +44 (0)161 2477 722
  • Munich:

    +49 (0)89 244 459800

Copyright © 2025 Mewburn Ellis. All rights reserved. Terms and Conditions & Online Privacy